MedPath
HSA Approval

METOCLOPRAMIDE TABLET 10 mg

SIN02804P

METOCLOPRAMIDE TABLET 10 mg

METOCLOPRAMIDE TABLET 10 mg

May 12, 1989

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A03FA01

metoclopramide

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PT ACTAVIS INDONESIA

Active Ingredients

METOCLOPRAMIDE HCl EQV ANHYDROUS METOCLOPRAMIDE HCl

10 mg

Metoclopramide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.